Re-Treatment of Relapsed Paget's Disease of Bone With Zoledronic Acid: Results From an Open-Label Study

BoneKEy Reports
doi 10.1038/bonekey.2013.176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portico

Related search

Treatment of Paget's Disease of Bone

BMJ
1988English

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Paget's Disease of Bone

Postgraduate Medical Journal
Medicine
1970English

A Family Study of Paget's Disease of Bone.

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
1983English

Life-Threatening Hyperkalemia Following Zoledronic Acid Infusion for Paget's Disease: A Case Report

Journal of Medical Case Reports
Medicine
2011English

Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study

Nutrition and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Paget's Disease of Bone--A Clinical and Genetic Study.

Postgraduate Medical Journal
Medicine
1977English

Enduring Efficacy and Tolerability of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma ( GEN 503): Final Results of an Open‐label, Phase 1/2 Study

British Journal of Haematology
Hematology
2019English

Paget's Disease in Temporal Bone

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy